Indaptus Therapeutics, Inc. (INDP) Debt Components
- 2025-07-27: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m); Debt Instrument, Face AmountUSD $6.80M; Debt Instrument, Convertible, Conversion PriceUSD/shares 8.30.
- 2025-06-30: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD $5.70M; Debt Instrument, Face AmountUSD (m); Debt Instrument, Convertible, Conversion PriceUSD/shares (m).
- 2025-06-30: Convertible Notes Payable, CurrentUSD $6.50M; Convertible Notes PayableUSD (m); Debt Instrument, Face AmountUSD $6.50M; Debt Instrument, Convertible, Conversion PriceUSD/shares 9.27.
Indaptus Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Convertible Notes Payable USD | Debt Instrument, Face Amount USD | Debt Instrument, Convertible, Conversion Price USD/shares |
|---|---|---|---|---|
| 2025-07-27 | (m) | (m) | $6.80M | 8.30 |
| 2025-06-30 | (m) | $5.70M | (m) | (m) |
| 2025-06-30 | $6.50M | (m) | $6.50M | 9.27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |